Research Article

Effects of Haloperidol, Olanzapine, Risperidone And Clozapine on Mice Detrusor Muscle Using Organ Bath System

Volume: 7 Number: 1 March 1, 2022
EN TR

Effects of Haloperidol, Olanzapine, Risperidone And Clozapine on Mice Detrusor Muscle Using Organ Bath System

Abstract

Objective: The bladder normally shows no contractility or activity during the filling phase. In the overactive urinary bladder, spontaneous contractions and detrusor instability are seen in the filling phase and urinary incontinence occurs. This study aims to demonstrate the effects of first-generation antipsychotic haloperidol and second-generation antipsychotics olanzapine, risperidone, and clozapine on mice isolated bladder using the organ bath system.
Materials and Methods: 63 male inbred mice were divided as saline, haloperidol 0.125 mg/kg, haloperidol 0.25 mg/kg, olanzapine 1 mg/kg, olanzapine 2 mg/kg, risperidone 0.25 mg/kg, risperidone 0.5 mg/kg, clozapine 1.25 mg/kg and clozapine 2.5 mg/kg groups. Mice were treated with drugs for 21 days. Then, the effects of drugs were investigated on isoproterenol-induced relaxation responses of carbachol-induced contractions in isolated detrusor strips.
Results: We showed that carbachol-induced contractions relaxed by isoproterenol and papaverine in mice detrusor strips obtained from olanzapine, risperidone, and clozapine treated groups. There were no significant differences in KCl-induced contractile responses among the groups.
Conclusion: Olanzapine, risperidone, and clozapine increased the isoproterenol-induced relaxations of the detrusor muscle that increased the bladder capacity. These drugs might be clinically useful for the treatment of overactive urinary bladder in patients that should use antipsychotic drugs. 

Keywords

References

  1. Truzzi JC, Gomes CM, Bezerra CA, et al. Overactive bladder – 18 years – part I. Int Braz J Urol. 2016;42(2):188-198. doi:10.1590/S1677-5538.IBJU.2015.0365
  2. Chuang YC, Liu SP, Lee KS, et al. Prevalence of overactive bladder in China, Taiwanand South Korea: results from a cross‐sectional, population-based study. Low Urin Tract Symptoms. 2019;11(1):48-55. doi:10.1111/luts.12193
  3. Xu H, Yang HJ, Rose GM. Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1) and D(2) receptors in the caudate putamen of C57BL/6 mouse. Life Sci. 2012;91(9-10):322-328. doi:10.1016/j.lfs.2012.07.025
  4. Lee PE, Gill SS, Rochon P. Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia. Neuropsychiatr Dis Treat. 2006;2(4):521-529. doi:10.2147/nedt.2006.2.4.521
  5. Kondej M, Stępnicki P, Kaczor AA. Multi-target approach for drug discovery against schizophrenia. Int J Mol Sci. 2018;19(10):3105. doi:10.3390/ijms19103105
  6. Colli E, Digesu GA, Olivieri L. Overactive bladder treatments in early phase clinical trials. Expert Opin Investig Drugs. 2007;16(7):999-1007. doi:10.1517/13543784.16.7.999
  7. Ulak G, Gumuslu E, Mutlu O, Ertan M, Komsuoglu Celikyurt I, Akar F, Erden F. Effects of olanzapine, clozapine, risperidone and sertindole on FGF2, synapsin and NGF expression in the hippocampus of naive mice. Int J Neuropsychopharmacol. 2016; 19(Suppl 1): 63–64. doi: 10.1093/ijnp/pyw041.45
  8. Tanyeri MH, Buyukokuroglu ME, Tanyeri P, Mutlu O, Ulak G, Yildiz Akar F, Erden BF. The effects of chronic treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens. Int J Neuropsychopharmacol. 2016; 19(Suppl 1): 37. doi: 10.1093/ijnp/pyw044.648

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

March 1, 2022

Submission Date

December 8, 2021

Acceptance Date

January 25, 2022

Published in Issue

Year 2022 Volume: 7 Number: 1

AMA
1.Tanyeri MH, Büyükokuroğlu ME, Tanyeri P, et al. Effects of Haloperidol, Olanzapine, Risperidone And Clozapine on Mice Detrusor Muscle Using Organ Bath System. OTJHS. 2022;7(1):106-111. doi:10.26453/otjhs.1034188

Creative Commons License
 

Online Türk Sağlık Bilimleri Dergisi [Online Turkish Journal of Health Sciences (OTJHS)] is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an open-access journal distributed under the terms of the Creative Commons Attribution License (CC BY-NC 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Click here to get help about article submission processes and "Copyright Transfer Form".